Shanghai Hile Bio-Technology Co (SHSE:603718) Cyclically Adjusted Revenue per Share: ¥0.46 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603718 Shanghai Hile Bio-Technology Co Ltd SHSE:603718
50 GF Score
Price ¥3.13
GF Value ¥4.20
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share?

Shanghai Hile Bio-Technology Co SHSE:603718 +3.99% 50 Cyclically Adjusted Revenue per Share is ¥0.46 as of Mar. 2026. GuruFocus rates SHSE:603718 with a GF Score™ of 50/100 and a GF Value™ of ¥4.20 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shanghai Hile Bio-Technology Co's adjusted revenue per share for the three months ended in Mar. 2026 was ¥0.075. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥0.46 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Hile Bio-Technology Co's average Cyclically Adjusted Revenue Growth Rate was -17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-25), Shanghai Hile Bio-Technology Co's current stock price is ¥3.13. Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥0.46. Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio of today is 6.80.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Hile Bio-Technology Co was 19.64. The lowest was 5.67. And the median was 13.47.


Shanghai Hile Bio-Technology Co  (SHSE:603718) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.13/0.46
=6.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Hile Bio-Technology Co was 19.64. The lowest was 5.67. And the median was 13.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Related Terms


Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.58 0.56 0.48

Shanghai Hile Bio-Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.52 0.49 0.48 0.46

SHSE:603718 vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603718
50GF Score
Shanghai Hile Bio-Technology Co Ltd SHSE:603718
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Hile Bio-Technology Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.075/116.3033*116.3033
=0.075

Current CPI (Mar. 2026) = 116.3033.

Shanghai Hile Bio-Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.200 101.400 0.229
201609 0.139 102.400 0.158
201612 0.136 102.600 0.154
201703 0.117 103.200 0.132
201706 0.102 103.100 0.115
201709 0.153 104.100 0.171
201712 0.110 104.500 0.122
201803 0.090 105.300 0.099
201806 0.077 104.900 0.085
201809 0.136 106.600 0.148
201812 0.083 106.500 0.091
201903 0.126 107.700 0.136
201906 0.090 107.700 0.097
201909 0.121 109.800 0.128
201912 0.101 111.200 0.106
202003 0.088 112.300 0.091
202006 0.097 110.400 0.102
202009 0.119 111.700 0.124
202012 0.071 111.500 0.074
202103 0.157 112.662 0.162
202106 0.104 111.769 0.108
202109 0.154 112.215 0.160
202112 0.119 113.108 0.122
202203 0.132 114.335 0.134
202206 0.133 114.558 0.135
202209 0.157 115.339 0.158
202212 0.043 115.116 0.043
202303 0.100 115.116 0.101
202306 0.083 114.558 0.084
202309 0.118 115.339 0.119
202312 0.073 114.781 0.074
202403 0.189 115.227 0.191
202406 0.039 114.781 0.040
202409 0.102 115.785 0.102
202412 0.147 114.893 0.149
202503 0.113 115.116 0.114
202506 0.062 114.907 0.063
202509 0.059 115.471 0.059
202512 0.056 115.832 0.056
202603 0.075 116.303 0.075

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥0.46 mean?
Shanghai Hile Bio-Technology Co (SHSE:603718) has a Cyclically Adjusted Revenue per Share of ¥0.46 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai Hile Bio-Technology Co and its competitors.
Is Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share too high?
Shanghai Hile Bio-Technology Co's current Cyclically Adjusted Revenue per Share is ¥0.46. Overall, Shanghai Hile Bio-Technology Co has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share of ¥0.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shanghai Hile Bio-Technology Co and its competitors. Shanghai Hile Bio-Technology Co's current Cyclically Adjusted Revenue per Share is ¥0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Hile Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co (SHSE:603718) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥4.20, compared to a current price of ¥3.13 — trading 25.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥0.46. Shanghai Hile Bio-Technology Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shanghai Hile Bio-Technology Co (SHSE:603718), the current Cyclically Adjusted Revenue per Share is ¥0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued. The current stock price of ¥3.13 is trading 25.5% below its estimated GF Value™ of ¥4.20. GuruFocus considers Shanghai Hile Bio-Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:603718:

  • Cyclically Adjusted Revenue per Share: ¥0.46
  • GF Value™: ¥4.20 vs. price of ¥3.13 (25.5% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Hile Bio-Technology Co Business Description

Address Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
50GF Score

Get the complete analysis for SHSE:603718

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.13
Price
¥4.20
GF Value